In the realm of clinical medicine, unexplained weight loss (UWL) presents a diagnostic challenge. It can be a harbinger of various underlying conditions, including malignancies, endocrine disorders, gastrointestinal diseases, and psychiatric illnesses. This article aims to provide a comprehensive approach to evaluating UWL in a clinical setting.
Initial assessment should include a detailed history and physical examination. The history should focus on the duration and amount of weight loss, dietary intake, symptoms of systemic diseases, and psychiatric evaluation. The physical examination should target signs of chronic diseases and nutritional deficiencies.
Basic laboratory studies, including complete blood count, metabolic panel, liver function tests, thyroid function tests, and urinalysis, should be conducted. Imaging studies should be reserved for patients with alarming symptoms or specific findings in the history or physical examination.
For older adults, malignancies and social factors like isolation and depression should be considered. In younger patients, eating disorders and malabsorption syndromes are more common. For patients with HIV/AIDS, opportunistic infections and medication side effects should be evaluated.
Management should be directed towards the underlying cause, if identified. For patients in whom no specific cause is found, a symptom-directed approach should be adopted. Regular follow-up is crucial to monitor weight and assess response to management.
Unexplained weight loss can be a symptom of a myriad of underlying diseases. A thorough and systematic approach to evaluation can help identify the cause and guide management. Understanding the potential causes and tailoring the evaluation to individual patient characteristics can improve outcomes and minimize unnecessary investigations.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation